You are going to see the companies that own the big GLP1s start trialing them for all kinds of stuff, PMOS is going to be on that list. They are already working on fatty liver, osteoarthritis, and addiction studies. Every new thing they get them approved for is an additional chunk of the population they can sell to and another condition that can be used to bill insurance. Not to mention new diseases being treated has patent and generic implications for them.I had typed out a long reply. Then figured no one would likely be interested.
I think if the name change helps us patients to understand they have a metabolic disorder which is wide ranging and acting on many body systems - hey it’s not just an ovary problem
It’s great that they changed the name but hey how about some help over here? 👋
My endo was forced to admit no new advances in treatments for PMOS in last ten years. We are not offered any help. I had to fight to see an endochronologist. I’d reached the end of the road as far as mainstream medicine goes. Nowhere to turn. No help. This is what brought me to grey in the end.
GLP1s are the way. They are the help some of us need to get things in our disrupted chaotic metabolic pathways under control.
Also I recommend looking into inositol for a safe & side effect free benefits. Not a peptide. Legal to buy it’s a health supplement. Get a jar of the powder on Amazon. Esp helpful for women & trans people of normal weight who have PMOS. They wouldn’t qualify or want to go for GLP1s. For me a game changer. It was the only thing that helped regulate my period. And I tried everything.
My endochronologist had never even heard of it. Brought a meta analysis to my next appointment 😀
gives doctors more cover to prescribe it too though as a lot of those conditions are exacerbated by being overweight/obese, so it's not all bad if you have decent insuranceYou are going to see the companies that own the big GLP1s start trialing them for all kinds of stuff, PMOS is going to be on that list. They are already working on fatty liver, osteoarthritis, and addiction studies. Every new thing they get them approved for is an additional chunk of the population they can sell to and another condition that can be used to bill insurance. Not to mention new diseases being treated has patent and generic implications for them.